Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?

Lotus L. van den Hoogen*, Gaby Smits, Cheyenne C.E. van Hagen, Denise Wong, Eric R.A. Vos, Michiel van Boven, Hester E. de Melker, Jeffrey van Vliet, Marjan Kuijer, Linde Woudstra, Alienke J. Wijmenga-Monsuur, Corine H. GeurtsvanKessel, Susanne P. Stoof, Daphne Reukers, Lisa A. Wijsman, Adam Meijer, Chantal B.E.M. Reusken, Nynke Y. Rots, Fiona R.M. van der Klis, Robert S. van BinnendijkGerco den Hartog

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

27 Citations (Scopus)
20 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?'. Together they form a unique fingerprint.

Immunology and Microbiology

Medicine and Dentistry